MAGEE THOMSON INVESTMENT PARTNERS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.

Quarter-by-quarter ownership
MAGEE THOMSON INVESTMENT PARTNERS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$183,000
+13.0%
3,4270.0%0.04%
+12.5%
Q3 2014$162,000
-24.3%
3,4270.0%0.04%
-23.1%
Q2 2014$214,000
+12.6%
3,427
+21.4%
0.05%
+20.9%
Q1 2014$190,000
+27.5%
2,8220.0%0.04%
+30.3%
Q4 2013$149,000
+129.2%
2,822
+86.6%
0.03%
+153.8%
Q3 2013$65,0001,5120.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders